Buy & Sell Vipshop Holdings Ltd - ADR (VIPS) – Vipshop Holdings Ltd - ADR Price Today
Aura AI Summary
Key Stats
- $7.07BMarket Cap
- Consumer CyclicalSector
- -22.08%3M Drawdown
- $3.83BEnterprise Value
- 4.21%Dividend Yield
- 56% Buy | 44% SellTrading Activity
- 41 daysTypical Hold Time
Vipshop Holdings Ltd - ADR (VIPS) is currently valued at a market capitalization of $7.07B, with an enterprise value of $3.83B. Over the past 52 weeks, Vipshop Holdings Ltd - ADR has traded between a low of $13.79 and a high of $20.68, highlighting its annual price range. Over the past three months, Vipshop Holdings Ltd - ADR has recorded a drawdown of -22.08%, reflecting recent price volatility. Vipshop Holdings Ltd - ADR offers a dividend yield of 4.21%, with the most recent dividend of $0.62 paid on 10 Apr 26. On average, investors hold Vipshop Holdings Ltd - ADR for approximately 41 days, indicating typical investor behavior on the platform.
About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Most Recent News
CallPhantom scam apps on Google Play fake call logs but charge real money, downloaded 7.3M+ times.
ESET researchers uncovered 28 fraudulent Android apps named CallPhantom on Google Play that falsely claim to provide call logs, SMS, and WhatsApp history for any phone number in exchange for payment. These apps, downloaded over 7.3 million times, gen...
Oculis secures FDA agreement on trial design for Privosegtor in optic neuritis treatment
Oculis Holding AG has received FDA Special Protocol Assessment (SPA) approval for its Phase 3 PIONEER-1 trial of Privosegtor, a novel neuroprotective drug for optic neuritis (ON). This agreement confirms the trial design is suitable to support a futu...
Pakistan’s HBL launches Temenos Core Banking, modernizing 40M accounts across 200 branches.
Habib Bank Limited (HBL) in Pakistan has successfully implemented Temenos Core Banking, marking a major modernization effort. The initial phase migrated accounts from 200 branches, supporting both Conventional and Islamic banking. Once fully deployed...